多变的 | LPV / R. | 没有lpv / r | p值 |
耐心 | 78. | 42. | |
年龄段 | 50(34-61) | 57(36.5-66) | 0.11 |
男性 | 35(44.9) | 19(45.2) | 0.83 |
目前的吸烟者 | 8(10.3) | 4(9.5) | 0.74 |
合并 | |||
Hypertension | 19(24.4) | 13(31.0) | 0.39 |
Diabetes | 8(10.3) | 2(4.8) | 0.49 |
Cardiac disease# | 5(6.4) | 2(4.8) | 1.00 |
Stroke | 2(2.6) | 1(2.4) | 1.00 |
COPD or asthma | 1(1.3) | 1(2.4) | 0.34 |
Chronic renal insufficiency | 1(1.3) | 0(0) | |
Malignancy | 4(5.1) | 3(7.1) | 0.69 |
疾病严重程度 | 0.02 | ||
General | 53(67.9) | 36(85.7) | |
Severe | 25(32.1) | 5(11.9) | |
Critical | 0(0) | 1(2.4) | |
录取实验室调查结果 | |||
White blood cell count ×109.细胞·L.-1 | 0.32 | ||
<4 | 22(28.2) | 5(11.9) | |
4–10 | 49(62.8) | 33(78.6) | |
>10 | 7(9.0) | 3(7.1) | |
Lymphocyte count ×109.淋巴细胞·L.-1 | |||
<0.8 | 25(32.6) | 4(9.5) | 0.01 |
Platelet count ×109.血小板·L.-1 | |||
<100 | 6(7.7) | 1(2.4) | 0.42 |
Creatinine level μmol·L-1 | |||
>133 | 1(1.3) | 3(7.1) | 0.11 |
AST level U·L-1 | |||
>40 | 21(26.9) | 12(28.6) | 0.87 |
治疗 | |||
Corticosteroid therapy | 44(56.4) | 10(23.8) | 0.001 |
Antibiotics | 73(93.6) | 30(71.4) | 0.001 |
High-flow nasal canula oxygen therapy | 17(21.8) | 4(9.5) | 0.13 |
Noninvasive mechanical ventilation | 1(1.3) | 1(2.4) | 1.00 |
Invasive mechanical ventilation | 1(1.3) | 0(0) | 1.00 |
结果 | |||
Viral shedding days | 22(18-29) | 28.5(19.5-38) | 0.02 |
Hospital length of stay days | 23(19-27) | 18.5(13-22.5) | <0.01 |
除非另有说明,否则数据呈现为N,中位数(句子范围)或N(%)。AST:天冬氨酸氨基转移酶。#:包括充血性心脏病和冠状动脉粥样硬化心脏病。